Synthetic cannabinoids, sold under labels such as "synthetic marijuana," "herbal incense," "potpourri," and "spice" have been tied to hospitalizations for unexplained acute kidney injury in the United States, according to research published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.
Use of an artificial intelligence framework can improve patient outcomes at one-third of the costs of the current standard of care, according to a study published online Jan. 2 in Artificial Intelligence in Medicine.
Neisseria gonorrhoeae has developed antimicrobial resistance since the 1930s and may be developing resistance to cephalosporins, according to research published in the Feb. 15 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.
The levels of bisphenol A in the urine of premature infants in the neonatal intensive care unit is associated with greater exposure to medical devices, but not with nutritional intake, according to a study published online Feb. 18 in Pediatrics.
In 2011, decreases were noted for some health care-associated infections, according to a report prepared by the U.S. Centers for Disease Control and Prevention.
Targeted biopsy for prostate cancer performed on suspicious lesions identified using computerized transrectal ultrasound-magnetic resonance imaging registration is associated with increased overall cancer detection rate, according to research published in the February issue of The Journal of Urology.
Increased exercise is associated with a lower risk of prostate cancer in white men, according to a study published online Feb. 11 in Cancer.
Compared with final pathology, biopsy of small renal masses can be accurately used in a treatment algorithm to direct management, according to research published in the February issue of The Journal of Urology.
Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen levels in men with lower urinary tract symptoms, according to research published in the February issue of The Journal of Urology.
For men with chronic pain taking opioids on a daily basis, hypogonadism occurs significantly more frequently in those taking long-acting opioids compared with short-acting opioids, according to a study published online Jan. 24 in the Clinical Journal of Pain.
